Impact of common diabetes risk variant in MTNR1B on sleep, circadian, and melatonin physiology

Diabetes

Volumn 65, Issue 6, 2016, Pages 1741-1751

  Lane, Jacqueline M ^a,b,c   Chang, Anne Marie ^b,c,d,e   Bjonnes, Andrew C ^a,b,c   Aeschbach, Daniel ^c,d,f   Anderson, Clare ^c,d   Cade, Brian E ^c,d   Cain, Sean W ^c,d   Czeisler, Charles A ^c,d   Gharib, Sina A ^g   Gooley, Joshua J ^c,d,p   Gottlieb, Daniel J ^c,d   Grant, Struan F A ^h,i   Klerman, Elizabeth B ^c,d   Lauderdale, Diane S ^j   Lockley, Steven W ^c,d,k   Munch, Miriam ^c,d,o   Patel, Sanjay ^c,d   Punjabi, Naresh M ^l   Rajaratnam, Shanthakumar M W ^c,d,k   Rueger, Melanie ^c,d   St Hilaire, Melissa A ^c,d   Santhi, Nayantara ^c,d,q   Scheuermaier, Karin ^c,d,r   Van Reen, Eliza ^c,d,s   Zee, Phyllis C ^m   Shea, Steven A ^c,d   Duffy, Jeanne F ^c,d   Buxton, Orfeu M ^c,d,e,n   Redline, Susan ^c,d   Scheer, Frank A J L ^c,d   Saxena, Richa ^a,b,c   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

^f GERMAN AEROSPACE CENTER DLR   (Germany)

^g UNIVERSITY OF WASHINGTON   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j UNIVERSITY OF CHICAGO   (United States)

^k MONASH UNIVERSITY   (Australia)

^l JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m NORTHWESTERN UNIVERSITY   (United States)

ⁿ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^o CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^p DUKE NUS MEDICAL SCHOOL   (Singapore)

^q UNIVERSITY OF SURREY   (United Kingdom)

^r UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^s BROWN UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MELATONIN; GLUCOSE BLOOD LEVEL; MELATONIN 2 RECEPTOR; MTNR1B PROTEIN, HUMAN;

ACTIMETRY; ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INSULIN RELEASE; MALE; MTNR1B GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; SELF REPORT; SLEEP; SLEEP TIME; ALLELE; ANALYSIS; BLOOD; DIET RESTRICTION; GENETIC VARIATION; GENETICS; GLUCOSE BLOOD LEVEL; PATHOPHYSIOLOGY; PHENOTYPE; RISK FACTOR; SECRETION (PROCESS); YOUNG ADULT;

ADULT; ALLELES; BLOOD GLUCOSE; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GENETIC VARIATION; HUMANS; MALE; MELATONIN; PHENOTYPE; RECEPTOR, MELATONIN, MT2; RISK FACTORS; SLEEP; YOUNG ADULT;

EID: 84969792045     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-0999     Document Type: Article

References (45)

1. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2010;33:414-420
2. Spiegel K, Tasali E, Leproult R, Van Cauter E. Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol 2009;5:253-261
3. Bass J, Takahashi JS. Circadian integration of metabolism and energetics. Science 2010;330:1349-1354
4. Scheer FAJL, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A 2009;106:4453-4458
5. McMullan CJ, Schernhammer ES, Rimm EB, Hu FB, Forman JP. Melatonin secretion and the incidence of type 2 diabetes. JAMA 2013;309:1388-1396
6. Rubio-Sastre P, Scheer FA, Gómez-Abellán P, Madrid JA, Garaulet M. Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening. Sleep 2014;37:1715-1719
7. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009;41:89-94
8. Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009;41:77-81
9. Karamitri A, Renault N, Clement N, Guillaume JL, Jockers R. Minireview: Toward the establishment of a link between melatonin and glucose homeostasis: association of melatonin MT2 receptor variants with type 2 diabetes. Mol Endocrinol 2013;27:1217-1233
10. Cagnacci A, Arangino S, Renzi A, et al. Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women. Clin Endocrinol (Oxf) 2001;54:339-346
11. Lyssenko V, Nagorny CL, Erdos MR, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009;41:82-88
12. Gaulton KJ, Ferreira T, Lee Y, et al.; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet 2015;47:1415-1425
13. Bonnefond A, Clément N, Fawcett K, et al.; Meta-Analysis of Glucose and Insulin-Related Traits Consortium (MAGIC). Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 2012;44:297-301
14. Nedeltcheva AV, Scheer FA. Metabolic effects of sleep disruption, links to obesity and diabetes. Curr Opin Endocrinol Diabetes Obes 2014;21:293-298
15. Depner CM, Stothard ER, Wright KP Jr. Metabolic consequences of sleep and circadian disorders. Curr Diab Rep 2014;14:507
16. Chang AM, Buch AM, Bradstreet DS, Klements DJ, Duffy JF. Human diurnal preference and circadian rhythmicity are not associated with the CLOCK 3111C/T gene polymorphism. J Biol Rhythms 2011;26:276-279
17. Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976;4:97-110
18. Brown EN, Czeisler CA. The statistical analysis of circadian phase and amplitude in constant-routine core-temperature data. J Biol Rhythms 1992;7:177-202
19. Chang AM, Scheer FA, Czeisler CA. The human circadian system adapts to prior photic history. J Physiol 2011;589:1095-1102
20. Duffy JF, Dijk DJ. Getting through to circadian oscillators: why use constant routines? J Biol Rhythms 2002;17:4-13
21. Czeisler CA, Duffy JF, Shanahan TL, et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999;284:2177-2181
22. Duffy JF, Dijk DJ, Klerman EB, Czeisler CA. Later endogenous circadian temperature nadir relative to an earlier wake time in older people. Am J Physiol 1998;275:R1478-R1487
23. Kleitman N. Sleep and Wakefulness. University of Chicago Press, 1963
24. St. Hilaire MA, Gronfier C, Zeitzer JM, Klerman EB. A physiologically based mathematical model of melatonin including ocular light suppression and interactions with the circadian pacemaker. J Pineal Res 2007;43:294-304
25. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909
26. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575
27. Musunuru K, Lettre G, Young T, et al.; NHLBI Candidate Gene Association Resource. Candidate-gene Association Resource (CARe): design, methods, and proof of concept. Circ Cardiovasc Genet 2010;3:267-275
28. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989;129:687-702
29. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105-1116
30. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991;1:263-276
31. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 1951;41:279-281
32. Bild DE, Bluemke DA, Burke GL, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002;156:871-881
33. Quan SF, Howard BV, Iber C, et al. The Sleep Heart Health Study: design, rationale, and methods. Sleep 1997;20:1077-1085
34. Castro-Diehl C, Diez Roux AV, Redline S, Seeman T, Shrager SE, Shea S. Association of sleep duration and quality with alterations in the hypothalamic-pituitary adrenocortical axis: the Multi-Ethnic Study of Atherosclerosis (MESA). J Clin Endocrinol Metab 2015;100:3149-3158
35. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213
36. Redline S, Kapur VK, Sanders MH, et al. Effects of varying approaches for identifying respiratory disturbances on sleep apnea assessment. Am J Respir Crit Care Med 2000;161:369-374
37. Kales A, Rechtschaffen A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles, Brain Information Service at the University of California, 1968
38. Keating BJ, Tischfield S, Murray SS, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One 2008;3:e3583
39. Gauderman W, Morrison JM. Quanto 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies [Internet], 2006. Avaliable from http://hydra.usc.edu/gxe. Accessed 3 January 2012
40. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010;26:2190-2191
41. Liu C, Wu Y, Li H, et al. MTNR1B rs10830963 is associated with fasting plasma glucose, HbA1C and impaired beta-cell function in Chinese Hans from Shanghai. BMC Med Genet 2010;11:59
42. Olsson L, Pettersen E, Ahlbom A, Carlsson S, Midthjell K, Grill V. No effect by the common gene variant rs10830963 of the melatonin receptor 1B on the association between sleep disturbances and type 2 diabetes: results from the Nord-Trøndelag Health Study. Diabetologia 2011;54:1375-1378
43. Picinato MC, Haber EP, Cipolla-Neto J, Curi R, de Oliveira Carvalho CR, Carpinelli AR. Melatonin inhibits insulin secretion and decreases PKA levels without interfering with glucose metabolism in rat pancreatic islets. J Pineal Res 2002;33:156-160
44. Stumpf I, Mühlbauer E, Peschke E. Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic beta-cells. J Pineal Res 2008;45:318-327
45. Liao J, Li X, Wong TY, et al Impact of measurement error on testing genetic association with quantitative traits. PLoS One 2014;9:e87044